Grants per year
Personal profile
Research Interests
My clinical and research focus is epilepsy syndromes, genetics of epilepsy syndromes, and Dravet syndrome.
Certifications and Licenses
| Clinical Neurophysiology | |
| Child Neurology |
Training Experience
| 1993 | Residency, University of Arizona Health Science Center |
| 1997 | Fellowship, Saint Joseph's Hospital, Phoenix |
| 2001 | Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital) |
Education/Academic qualification
MD, Saint Louis University
… → 1990
Research interests
- EEG
- Epigenetics
- Epilepsy
- Pediatric Neurology
Fingerprint Dive into the research topics where Linda C Laux is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Myoclonic Epilepsy
Medicine & Life Sciences
Seizures
Medicine & Life Sciences
Cannabidiol
Medicine & Life Sciences
Epilepsy
Medicine & Life Sciences
Ketogenic Diet
Medicine & Life Sciences
Anticonvulsants
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Brain Diseases
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2013 2014
- 1 Finished
Research Output 2007 2020
A single-center, retrospective analysis of genotype-phenotype correlations in children with Dravet syndrome
Gertler, T. S., Calhoun, J. & Laux, L., Feb 2020, In : Seizure. 75, p. 1-6 6 p.Research output: Contribution to journal › Article
Myoclonic Epilepsy
Genetic Association Studies
Anticonvulsants
Comorbidity
Seizures
2
Citations
(Scopus)
Fenfluramine for Treatment-Resistant Seizures in Patients with Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial
Nabbout, R., Mistry, A., Zuberi, S., Villeneuve, N., Gil-Nagel, A., Sanchez-Carpintero, R., Stephani, U., Laux, L., Wirrell, E., Knupp, K., Chiron, C., Farfel, G., Galer, B. S., Morrison, G., Lock, M., Agarwal, A. & Auvin, S., Jan 1 2019, (Accepted/In press) In : JAMA Neurology.Research output: Contribution to journal › Article
Open Access
Myoclonic Epilepsy
Fenfluramine
Seizures
Randomized Controlled Trials
Placebos
3
Citations
(Scopus)
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
FAiRE DS Study Group, Dec 21 2019, In : The Lancet. 394, 10216, p. 2243-2254 12 p.Research output: Contribution to journal › Article
Myoclonic Epilepsy
Fenfluramine
Seizures
Placebos
Therapeutics
17
Citations
(Scopus)
Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
Devinsky, O., Nabbout, R., Miller, I., Laux, L. C., Zolnowska, M., Wright, S. & Roberts, C., Feb 1 2019, In : Epilepsia. 60, 2, p. 294-302 9 p.Research output: Contribution to journal › Article
Cannabidiol
Myoclonic Epilepsy
Seizures
Therapeutics
Caregivers
10
Citations
(Scopus)
Long-term safety and efficacy of cannabidiol in children and adults with treatmentresistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results
Laux, L. C., Bebin, E. M., Checketts, D., Chez, M., Flamini, R., Marsh, E. D., Miller, I., Nichol, K., Park, Y., Segal, E., Seltzer, L., Szaflarski, J. P., Thiele, E. A. & Weinstock, A., Aug 1 2019, In : Epilepsy Research. 154, p. 13-20 8 p.Research output: Contribution to journal › Article
Open Access
Cannabidiol
Myoclonic Epilepsy
Seizures
Safety
Anticonvulsants